Holland, Mich. – October 29, 2020 – Genesis Innovation Group’s cultivate(MD) Seed Fund, a fund focused on investments into early-stage healthcare companies with innovative technologies, announces that one of their portfolio companies, Norfolk, VA based Embody, Inc. has received FDA 510(k) clearance for their TAPESTRY® Biointegrative Implant for Tendon and Ligament Repair.
Company Prepares MIRA for Use in Minimally-Invasive Laparoscopic Colon Surgery
Holland, Mich., July 08, 2020 — HAPPE Spine announces that it has received notice of allowance from the U.S. Patent and Trademark Office for patent claims providing broad protections for its unique material and manufacturing technology providing fully porous, bioactive polyetheretherketone (PEEK) technology (U.S. Pat. App. No. 14/078,614).
HAPPE Spine Announces Additional Technology Patent for Porous and Bioactive PEEK Read More »
Embody, Inc., a privately-held medical device company focused on soft tissue repair, announced that it has closed a $9.3 million Series A funding round with participation from cultivate(MD).
Embody, Inc. Announces $9.3 M Series A Funding Round Read More »
Embody, a cultivate(MD) portfolio company, is receiving a $2.5 million Phase II Small Business Innovation Research award through the Defense Advanced Research Projects Agency (DARPA).
Embody Receives $2.5 Million Phase II Research Award Read More »
HOLLAND, Mich., Jan. 13, 2020 PRNewswire — Genesis Innovation Group’s cultivate(MD) Seed Fund, a fund focused on investments into early-stage healthcare companies with innovative technologies, announces its participation in Virtual Incision Corporation’s raise of $20 million in Series B+ financing. Virtual Incision is a medical device company pioneering the first-of-its-kind, miniaturized surgical robot and the
Virtual Incision, a cultivate(MD) portfolio company, announced today that it has closed announced it has raised $20 million in a Series B+ financing.
Virtual Incision Announces $20 Million Financing Read More »
A medical device startup in the region has received FDA clearance for a new product.
Medical Startup Receives FDA Clearance Read More »
HOLLAND, Mich., December 10th, 2019 — Shoulder Innovations, (SI), a leading innovator in the development of shoulder replacement systems, announced today that they have received FDA clearance for their InSet Plus™ augmented glenoids for the InSet™ Total Shoulder System.
